"10.1371_journal.ppat.1005325","plos pathogens","2015-12-11T00:00:00Z","Michael G Berg; Deanna Lee; Kelly Coller; Matthew Frankel; Andrew Aronsohn; Kevin Cheng; Kenn Forberg; Marilee Marcinkus; Samia N Naccache; George Dawson; Catherine Brennan; Donald M Jensen; John Hackett; Charles Y Chiu","Abbott Laboratories, Abbott Park, Illinois, United States of America; Department of Laboratory Medicine, University of California, San Francisco, California, United States of America; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, United States of America; Center for Liver Diseases, University of Chicago Medical Center, Chicago, Illinois, United States of America; Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, United States of America","Conceived and designed the experiments: MGB JH CYC. Performed the experiments: MGB DL KCh KCo MF MM. Analyzed the data: AA DMJ DL KCh KCo KF MF GD CB JH CYC. Contributed reagents/materials/analysis tools: SNN CYC. Wrote the paper: MGB KCo MF GD JH CYC.","I have read the journals policy and the authors of this manuscript have the following competing interests: CYC is the director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) and receives research support in pathogen discovery from Abbott Laboratories, Inc. MGB, KCh, KCo, KF, MF, MM, GD, CB, and JH are employees of Abbott Laboratories, Inc. DL, MGB, KCo, KCh, MF, JH, and CYC have filed a patent application related to the novel pegivirus, provisionally named human pegivirus 2 (HPgV-2). This does not alter our adherence to all PLOS policies on sharing data and materials.","2015","12","Michael G Berg","MGB",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
